Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Assets (2016 - 2025)

Historic Return on Assets for Cytosorbents (CTSO) over the last 14 years, with Q3 2025 value amounting to 0.35%.

  • Cytosorbents' Return on Assets rose 400.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.41% for FY2024, which is 900.0% up from last year.
  • Cytosorbents' Return on Assets amounted to 0.35% in Q3 2025, which was up 400.0% from 0.32% recorded in Q2 2025.
  • Cytosorbents' Return on Assets' 5-year high stood at 0.1% during Q1 2021, with a 5-year trough of 0.62% in Q3 2022.
  • Its 5-year average for Return on Assets is 0.4%, with a median of 0.43% in 2024.
  • In the last 5 years, Cytosorbents' Return on Assets skyrocketed by 4000bps in 2021 and then plummeted by -4500bps in 2022.
  • Over the past 5 years, Cytosorbents' Return on Assets (Quarter) stood at 0.27% in 2021, then plummeted by -97bps to 0.52% in 2022, then fell by -11bps to 0.58% in 2023, then rose by 26bps to 0.43% in 2024, then rose by 19bps to 0.35% in 2025.
  • Its last three reported values are 0.35% in Q3 2025, 0.32% for Q2 2025, and 0.33% during Q1 2025.